Russell Investments Group, Ltd. Reata Pharmaceuticals Inc Transaction History

Russell Investments Group, Ltd.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	SELL	$79.22 - $105.37 $3,644 - $4,847	-46 Reduced 37.1%	78 $7,000
Q1 2023 May 09, 2023	SELL	$30.85 - $93.17 $185,655 - $560,697	-6,018 Reduced 97.98%	124 $11,000
Q4 2022 Feb 08, 2023	BUY	$22.15 - $42.11 $22,017 - $41,857	994 Added 19.31%	6,142 $233,000
Q3 2022 Nov 04, 2022	BUY	$19.41 - $36.49 $99,922 - $187,850	5,148 New	5,148 $129,000
Q1 2022 May 05, 2022	SELL	$24.12 - $39.6 $1.02 Million - $1.67 Million	-42,089 Closed	0 $0
Q4 2021 Jan 21, 2022	BUY	$25.61 - $110.96 $22,383 - $96,979	874 Added 2.12%	42,089 $1.11 Million
Q3 2021 Nov 08, 2021	BUY	$100.0 - $143.02 $589,800 - $843,531	5,898 Added 16.7%	41,215 $4.15 Million
Q2 2021 Aug 04, 2021	BUY	$78.27 - $151.29 $2.76 Million - $5.34 Million	35,317 New	35,317 $5 Million
Q3 2020 Nov 09, 2020	SELL	$93.53 - $163.34 $541,258 - $945,248	-5,787 Closed	0 $0
Q2 2020 Aug 05, 2020	BUY	$126.3 - $176.56 $538,543 - $752,851	4,264 Added 279.97%	5,787 $902,000
Q1 2020 May 06, 2020	SELL	$124.16 - $247.74 $454,798 - $907,471	-3,663 Reduced 70.63%	1,523 $219,000
Q4 2019 Jan 29, 2020	BUY	$74.57 - $217.92 $200,518 - $585,986	2,689 Added 107.69%	5,186 $1.06 Million
Q3 2019 Nov 01, 2019	BUY	$71.26 - $95.75 $177,936 - $239,087	2,497 New	2,497 $200,000

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

Stay updated on Russell Investments Group, Ltd. with notifications on news.